Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | The risk or severity of adverse effects can be increased when Buflomedil is combined with Apixaban. |
| Dasatinib | Dasatinib may increase the anticoagulant activities of Buflomedil. |
| Ursodeoxycholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of adverse effects can be increased when Buflomedil is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of adverse effects can be increased when Buflomedil is combined with Hyodeoxycholic Acid. |
| Glucosamine | Glucosamine may increase the antiplatelet activities of Buflomedil. |
| Ibritumomab tiuxetan | The risk or severity of adverse effects can be increased when Buflomedil is combined with Ibritumomab tiuxetan. |
| Ibrutinib | The risk or severity of adverse effects can be increased when Ibrutinib is combined with Buflomedil. |
| Obinutuzumab | The risk or severity of adverse effects can be increased when Buflomedil is combined with Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the antiplatelet activities of Buflomedil. |
| Rivaroxaban | Buflomedil may increase the anticoagulant activities of Rivaroxaban. |
| Tipranavir | Tipranavir may increase the antiplatelet activities of Buflomedil. |
| Urokinase | Buflomedil may increase the anticoagulant activities of Urokinase. |
| Vitamin E | Vitamin E may increase the antiplatelet activities of Buflomedil. |
| Valsartan | Buflomedil may decrease the antihypertensive activities of Valsartan. |
| Ramipril | Buflomedil may decrease the antihypertensive activities of Ramipril. |
| Esmolol | Buflomedil may decrease the antihypertensive activities of Esmolol. |
| Betaxolol | Buflomedil may decrease the antihypertensive activities of Betaxolol. |
| Reserpine | Buflomedil may decrease the antihypertensive activities of Reserpine. |
| Remikiren | Buflomedil may decrease the antihypertensive activities of Remikiren. |
| Torasemide | Buflomedil may decrease the antihypertensive activities of Torasemide. |
| Guanadrel | Buflomedil may decrease the antihypertensive activities of Guanadrel. |
| Metoprolol | Buflomedil may decrease the antihypertensive activities of Metoprolol. |
| Isradipine | Buflomedil may decrease the antihypertensive activities of Isradipine. |
| Olmesartan | Buflomedil may decrease the antihypertensive activities of Olmesartan. |
| Chlorthalidone | Buflomedil may decrease the antihypertensive activities of Chlorthalidone. |
| Nitroprusside | Buflomedil may decrease the antihypertensive activities of Nitroprusside. |
| Atenolol | Buflomedil may decrease the antihypertensive activities of Atenolol. |
| Diltiazem | Buflomedil may decrease the antihypertensive activities of Diltiazem. |
| Minoxidil | Buflomedil may decrease the antihypertensive activities of Minoxidil. |
| Timolol | Buflomedil may decrease the antihypertensive activities of Timolol. |
| Amlodipine | Buflomedil may decrease the antihypertensive activities of Amlodipine. |
| Nimodipine | Buflomedil may decrease the antihypertensive activities of Nimodipine. |
| Nisoldipine | Buflomedil may decrease the antihypertensive activities of Nisoldipine. |
| Bendroflumethiazide | Buflomedil may decrease the antihypertensive activities of Bendroflumethiazide. |
| Prazosin | Buflomedil may decrease the antihypertensive activities of Prazosin. |
| Fosinopril | Buflomedil may decrease the antihypertensive activities of Fosinopril. |
| Trandolapril | Buflomedil may decrease the antihypertensive activities of Trandolapril. |
| Metolazone | Buflomedil may decrease the antihypertensive activities of Metolazone. |
| Lercanidipine | Buflomedil may decrease the antihypertensive activities of Lercanidipine. |
| Benazepril | Buflomedil may decrease the antihypertensive activities of Benazepril. |
| Bosentan | Buflomedil may decrease the antihypertensive activities of Bosentan. |
| Propranolol | Buflomedil may decrease the antihypertensive activities of Propranolol. |
| Enalapril | Buflomedil may decrease the antihypertensive activities of Enalapril. |
| Doxazosin | Buflomedil may decrease the antihypertensive activities of Doxazosin. |
| Labetalol | Buflomedil may decrease the antihypertensive activities of Labetalol. |
| Cyclothiazide | Buflomedil may decrease the antihypertensive activities of Cyclothiazide. |
| Bisoprolol | Buflomedil may decrease the antihypertensive activities of Bisoprolol. |
| Candoxatril | Buflomedil may decrease the antihypertensive activities of Candoxatril. |
| Nicardipine | Buflomedil may decrease the antihypertensive activities of Nicardipine. |
| Mecamylamine | Buflomedil may decrease the antihypertensive activities of Mecamylamine. |
| Losartan | Buflomedil may decrease the antihypertensive activities of Losartan. |
| Moexipril | Buflomedil may decrease the antihypertensive activities of Moexipril. |
| Eplerenone | Buflomedil may decrease the antihypertensive activities of Eplerenone. |
| Lisinopril | Buflomedil may decrease the antihypertensive activities of Lisinopril. |
| Nitroglycerin | Buflomedil may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | Buflomedil may decrease the antihypertensive activities of Metyrosine. |
| Hydroflumethiazide | Buflomedil may decrease the antihypertensive activities of Hydroflumethiazide. |
| Cryptenamine | Buflomedil may decrease the antihypertensive activities of Cryptenamine. |
| Perindopril | Buflomedil may decrease the antihypertensive activities of Perindopril. |
| Candesartan cilexetil | Buflomedil may decrease the antihypertensive activities of Candesartan cilexetil. |
| Fenoldopam | Buflomedil may decrease the antihypertensive activities of Fenoldopam. |
| Indapamide | Buflomedil may decrease the antihypertensive activities of Indapamide. |
| Tadalafil | Buflomedil may decrease the antihypertensive activities of Tadalafil. |
| Alprenolol | Buflomedil may decrease the antihypertensive activities of Alprenolol. |
| Eprosartan | Buflomedil may decrease the antihypertensive activities of Eprosartan. |
| Chlorothiazide | Buflomedil may decrease the antihypertensive activities of Chlorothiazide. |
| Quinapril | Buflomedil may decrease the antihypertensive activities of Quinapril. |
| Pindolol | Buflomedil may decrease the antihypertensive activities of Pindolol. |
| Telmisartan | Buflomedil may decrease the antihypertensive activities of Telmisartan. |
| Methyldopa | Buflomedil may decrease the antihypertensive activities of Methyldopa. |
| Hydrochlorothiazide | Buflomedil may decrease the antihypertensive activities of Hydrochlorothiazide. |
| Trichlormethiazide | Buflomedil may decrease the antihypertensive activities of Trichlormethiazide. |
| Felodipine | Buflomedil may decrease the antihypertensive activities of Felodipine. |
| Irbesartan | Buflomedil may decrease the antihypertensive activities of Irbesartan. |
| Nitrendipine | Buflomedil may decrease the antihypertensive activities of Nitrendipine. |
| Deserpidine | Buflomedil may decrease the antihypertensive activities of Deserpidine. |
| Pentolinium | Buflomedil may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | Buflomedil may decrease the antihypertensive activities of Trimethaphan. |
| Diazoxide | Buflomedil may decrease the antihypertensive activities of Diazoxide. |
| Carvedilol | Buflomedil may decrease the antihypertensive activities of Carvedilol. |
| Bretylium | Buflomedil may decrease the antihypertensive activities of Bretylium. |
| Terazosin | Buflomedil may decrease the antihypertensive activities of Terazosin. |
| Guanethidine | Buflomedil may decrease the antihypertensive activities of Guanethidine. |
| Acebutolol | Buflomedil may decrease the antihypertensive activities of Acebutolol. |
| Captopril | Buflomedil may decrease the antihypertensive activities of Captopril. |
| Nadolol | Buflomedil may decrease the antihypertensive activities of Nadolol. |
| Bepridil | Buflomedil may decrease the antihypertensive activities of Bepridil. |
| Hydralazine | Buflomedil may decrease the antihypertensive activities of Hydralazine. |
| Bevantolol | Buflomedil may decrease the antihypertensive activities of Bevantolol. |